A study in healthy men to learn about how the body absorbs, processes, and removes radioactively labeled BAY 3283142
22127
Phase 1 other active
Quick answer
A study in healthy men to learn about how the body absorbs, processes, and removes radioactively labeled BAY 3283142 for Chronic kidney disease is a Phase 1 program (other) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Chronic kidney disease
- Phase
- Phase 1
- Modality
- other
- Status
- active